Dr. Elaine Shum, MD
Claim this profileNYU Langone Health
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
16 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
NYU Langone Health
Laura And Isaac Perlmutter Cancer Center At NYU Langone
Clinical Trials Elaine Shum, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Elaine Shum, MD
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Elaine Shum, MD has experience with
- Atezolizumab
- PD-1 Inhibitor
- NC318
- Osimertinib
- Ramucirumab
- Cisplatin
Breakdown of trials Elaine Shum, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elaine Shum, MD specialize in?
Elaine Shum, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Elaine Shum, MD currently recruiting for clinical trials?
Yes, Elaine Shum, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Elaine Shum, MD has studied deeply?
Yes, Elaine Shum, MD has studied treatments such as Atezolizumab, PD-1 inhibitor, NC318.
What is the best way to schedule an appointment with Elaine Shum, MD?
Apply for one of the trials that Elaine Shum, MD is conducting.
What is the office address of Elaine Shum, MD?
The office of Elaine Shum, MD is located at: NYU Langone Health, New York, New York 10016 United States. This is the address for their practice at the NYU Langone Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.